Log In
Print
BCIQ
Print
Print this Print this
 

RGN-259

  Manage Alerts
Collapse Summary General Information
Company RegeneRx Biopharmaceuticals Inc.
DescriptionTopical eye drop formulation of thymosin beta 4 (TB4), a naturally occurring 43-amino acid peptide
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today